Thomas J Stocker1, Simon Deseive2, Marcus Chen3, Jonathon Leipsic4, Martin Hadamitzky5, Ronen Rubinshtein6, Erik L Grove7, Xiang-Ming Fang8, John Lesser9, Pál Maurovich-Horvat10, Hugo Marques11, Daniele Andreini12, Ramzi Tabbalat13, Joon-Won Kang14, Joachim Eckert15, Patricia Dickson16, Signe H Forsdahl17, Jess Lambrechtsen18, Roberto C Cury19, Jörg Hausleiter20. 1. Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-Universität, Munich, Germany. Electronic address: thomas.stocker@med.uni-muenchen.de. 2. Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-Universität, Munich, Germany. 3. National Heart, Lung, and Blood Institute, Bethesda, United States. 4. University of British Columbia, Vancouver, Canada. 5. Deutsches Herzzentrum, Munich, Germany. 6. Lady Davis Carmel Medical Center, Haifa, Israel. 7. Aarhus University Hospital, Aarhus, Denmark. 8. Wuxi People's Hospital, Wuxi, China. 9. Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, United States. 10. MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Budapest, Hungary. 11. UNICA (Cardiovascular Imaging Unit), Hospital da Luz, Lisbon, Portugal. 12. Centro Cardiologico Monzino, University of Milan, Milan, Italy. 13. Khalidi Hospital & Medical Center, Amman, Jordan. 14. Asan Medical Center, Seoul, South Korea. 15. Cardioangiologisches Centrum Bethanien (CCB), Frankfurt, Germany. 16. Capital Cardiology Associates, Albany, United States. 17. University Hospital North Norway, Tromsø, Norway. 18. Odense University Hospital, Svendborg, Denmark. 19. Delboni/DASA, Sao Paulo, Brazil. 20. Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-Universität, Munich, Germany. Electronic address: joerg.hausleiter@med.uni-muenchen.de.
Abstract
BACKGROUND: Cardiac computed tomography angiography (cardiac CTA) is an increasingly used versatile imaging method to evaluate coronary and cardiac morphology. Owing to improvements in technology, image quality has continuously improved over the last 10-20 years. At the same time, numerous non-randomized and randomized studies have been performed to reduce the associated radiation exposure. Currently, it is unclear if the advances in technology and knowledge about radiation reduction translated into reduced levels of cardiac CTA radiation dose in daily clinical practice as well as a wide utilization of dose-saving strategies. METHODS: The PROTECTION VI study is a multicenter, prospective, worldwide registry designed to evaluate radiation dose exposure, utilization of dose-saving strategies and diagnostic image quality during cardiac CTA in current daily practice. Assessment of image quality will be addressed by the evaluation of diagnostic image quality at the local study site and the calculation of quantitative image quality parameters in an imaging core laboratory. Above 4000 patients will be enrolled from approximately 70 sites in Europe, North America, South America, Asia and Australia. The study will analyze median radiation dose levels, image quality, frequency of use and efficacy of algorithms for dose reduction, and patient and study-related predictors associated with radiation dose. CONCLUSIONS: The PROTECTION VI study is designed to provide a reliable estimate of current radiation dose for cardiac CTA and to assess the potential for additional dose reductions.
BACKGROUND: Cardiac computed tomography angiography (cardiac CTA) is an increasingly used versatile imaging method to evaluate coronary and cardiac morphology. Owing to improvements in technology, image quality has continuously improved over the last 10-20 years. At the same time, numerous non-randomized and randomized studies have been performed to reduce the associated radiation exposure. Currently, it is unclear if the advances in technology and knowledge about radiation reduction translated into reduced levels of cardiac CTA radiation dose in daily clinical practice as well as a wide utilization of dose-saving strategies. METHODS: The PROTECTION VI study is a multicenter, prospective, worldwide registry designed to evaluate radiation dose exposure, utilization of dose-saving strategies and diagnostic image quality during cardiac CTA in current daily practice. Assessment of image quality will be addressed by the evaluation of diagnostic image quality at the local study site and the calculation of quantitative image quality parameters in an imaging core laboratory. Above 4000 patients will be enrolled from approximately 70 sites in Europe, North America, South America, Asia and Australia. The study will analyze median radiation dose levels, image quality, frequency of use and efficacy of algorithms for dose reduction, and patient and study-related predictors associated with radiation dose. CONCLUSIONS: The PROTECTION VI study is designed to provide a reliable estimate of current radiation dose for cardiac CTA and to assess the potential for additional dose reductions.
Authors: Tobias F Jakobs; Christoph R Becker; Bernd Ohnesorge; Thomas Flohr; Christoph Suess; Uwe J Schoepf; Maximilian F Reiser Journal: Eur Radiol Date: 2002-02-21 Impact factor: 5.315
Authors: Andrew J Einstein; Kevin W Moser; Randall C Thompson; Manuel D Cerqueira; Milena J Henzlova Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Thomas G Flohr; Cynthia H McCollough; Herbert Bruder; Martin Petersilka; Klaus Gruber; Christoph Süss; Michael Grasruck; Karl Stierstorfer; Bernhard Krauss; Rainer Raupach; Andrew N Primak; Axel Küttner; Stefan Achenbach; Christoph Becker; Andreas Kopp; Bernd M Ohnesorge Journal: Eur Radiol Date: 2005-12-10 Impact factor: 5.315
Authors: Jelena R Ghadri; Silke M Küest; Robert Goetti; Michael Fiechter; Aju P Pazhenkottil; Rene N Nkoulou; Felix P Kuhn; Carsten Pietsch; Patrick von Schulthess; Oliver Gaemperli; Christian Templin; Philipp A Kaufmann Journal: Int J Cardiovasc Imaging Date: 2011-07-10 Impact factor: 2.357
Authors: Kristian Altern Øvrehus; Mohamed Marwan; Hans Erik Bøtker; Stephan Achenbach; Bjarne Linde Nørgaard Journal: Int J Cardiovasc Imaging Date: 2011-05-29 Impact factor: 2.357
Authors: Jörg Hausleiter; Tanja Meyer; Franziska Hermann; Martin Hadamitzky; Markus Krebs; Thomas C Gerber; Cynthia McCollough; Stefan Martinoff; Adnan Kastrati; Albert Schömig; Stephan Achenbach Journal: JAMA Date: 2009-02-04 Impact factor: 56.272
Authors: Matthew J Budoff; David Dowe; James G Jollis; Michael Gitter; John Sutherland; Edward Halamert; Markus Scherer; Raye Bellinger; Arthur Martin; Robert Benton; Augustin Delago; James K Min Journal: J Am Coll Cardiol Date: 2008-11-18 Impact factor: 24.094
Authors: Thomas J Stocker; Simon Deseive; Jonathon Leipsic; Martin Hadamitzky; Marcus Y Chen; Ronen Rubinshtein; Mathias Heckner; Jeroen J Bax; Xiang-Ming Fang; Erik Lerkevang Grove; John Lesser; Pál Maurovich-Horvat; James Otton; Sanghoon Shin; Gianluca Pontone; Hugo Marques; Benjamin Chow; Cesar H Nomura; Ramzi Tabbalat; Axel Schmermund; Joon-Won Kang; Christopher Naoum; Melany Atkins; Eugenio Martuscelli; Steffen Massberg; Jörg Hausleiter Journal: Eur Heart J Date: 2018-11-01 Impact factor: 29.983